-
Aurora Kinase A in Retinoblastoma: Study Insights
2026-08-25
This 2024 study identifies AURKA overexpression as a common feature of human retinoblastoma and links elevated kinase expression to histopathologic high-risk factors and poor chemotherapy response. Integrated patient-sample, cellular, and xenograft evidence supports AURKA as a biologically relevant target, while also highlighting the need for disease-specific validation before clinical translation.
-
THZ1 Workflows for CDK7-Driven Cancer Research
2026-08-24
THZ1 combines covalent CDK7 engagement with a practical workflow for connecting transcriptional disruption to antiproliferative and apoptotic phenotypes. Its strongest use-case differentiation is in state-aware T-ALL research, where exposure timing, washout design, and orthogonal readouts can reveal more than a single viability endpoint.
-
Baicalin: Workflow for Plasticity and Cancer Research
2026-08-24
Baicalin offers a research workflow that connects adult visual-cortex plasticity with pathway-focused oncology studies. The strongest use case is a controlled, dose-resolved design that pairs functional imaging or electrophysiology with mechanistic assays rather than treating a botanical extract as an equivalent substitute.
-
Tyrothricin Workflows for Antimicrobial Research
2026-08-23
Tyrothricin is a peptide antibiotic mixture suited to membrane-focused screening, time-kill experiments, fungal assays, and carefully controlled exploratory antiviral studies. This workflow emphasizes mixture-aware interpretation, fresh-solution handling, orthogonal readouts, and troubleshooting that separates antimicrobial activity from host-cell or assay artifacts.
-
Salinomycin: Translational Leverage in HCC Research
2026-08-22
Salinomycin connects ion transport, ABC drug transporter activity, Wnt/β-catenin modulation, and apoptosis in hepatocellular carcinoma research. This thought-leadership analysis explains the mechanistic rationale, evidence boundaries, experimental workflow, translational risks, and strategic opportunities for developing Salinomycin as a rigorous anti-cancer research tool.
-
Deep Learning Detects Cardiotoxicity in iPSC-CMs
2026-08-22
Grafton and colleagues developed a high-content screening strategy that combines induced pluripotent stem cell-derived cardiomyocytes with deep-learning image analysis to detect cardiotoxic phenotypes early in drug discovery. The approach converted complex cellular images into a single screening score and recovered liabilities across several pharmacological classes, supporting scalable, target-agnostic cardiac safety assessment.
-
XAV-939: Tankyrase Inhibition for Wnt Research
2026-08-21
XAV-939, also called NVP-XAV939, is a cell-permeable TNKS1/TNKS2 inhibitor that stabilizes axin and suppresses Wnt/β-catenin signaling. Its documented research uses include cancer research, fibrotic disease research, osteogenic differentiation, and bone formation disorder studies.
-
LEE011 Succinate: Practical CDK Inhibitor Workflows
2026-08-20
Build more reproducible cancer research around LEE011 succinate with linked proliferation, cell-cycle, and dissolution workflows. The guide translates pH-shift findings into practical assay controls while highlighting troubleshooting strategies for dose response, combination studies, and sample handling.
-
RG108 DNA Methyltransferase Inhibitor Workflow
2026-08-20
RG108 is a non-nucleosidic DNA methyltransferase inhibitor for reversible epigenetic perturbation without covalent enzyme trapping. This practical guide shows how to move from stock preparation and HL-60 treatment to methylation, transcription, viability, and pathway assays in cancer research.
-
WST-8 Glucose Uptake Assay Kit for Metabolism
2026-08-19
Translate transporter activity and insulin-response experiments into a quantitative, non-radioactive colorimetric readout. This workflow shows how the WST-8 Glucose Uptake Assay Kit can connect Galectin-1–FIP200 biology with functional glucose handling in hepatic steatosis models.
-
iPSC Lines from Twins Discordant for Schizophrenia
2026-08-19
The reference study generated and characterized two human iPSC lines from dizygotic twins in which one sibling had schizophrenia and the other did not. The paired, quality-controlled resource provides a useful starting point for investigating genetic and environmental contributions to schizophrenia and for developing patient-relevant neural models.
-
Myriocin and the Translational Logic of SPT Inhibition
2026-08-18
Myriocin is a potent serine palmitoyltransferase inhibitor that connects sphingolipid metabolism research with cancer biology, immunology, and metabolic disease. This thought-leadership analysis examines how recent mouse data, assay strategy, and translational discipline can turn SPT inhibition into a more informative research platform.
-
Müller Cell PEDF and Retinal Neuron Survival
2026-08-18
Younis and colleagues identify Müller cell-derived pigment epithelium-derived factor (PEDF) as a key mediator of angiopoietin-regulated retinal neuron survival. Their co-culture, knockdown, hypoxia, and signaling experiments connect Ang-1/Ang-2 balance with Müller cell Tie-2–PI3K/Akt activity and PEDF/PEDF-R-dependent neuroprotection.
-
PF-562271 HCl Workflow for FAK/Pyk2 Studies
2026-08-17
Build reproducible adhesion, migration, phosphorylation, and tumor-model assays with PF-562271 HCl, a reversible FAK/Pyk2 inhibitor with nanomolar biochemical potency. The workflow also shows how findings from therapy-resistant HER2-positive breast cancer research can inform, but not replace, direct validation of focal adhesion kinase signaling experiments.
-
Roscovitine for CDK and Cell-Cycle Studies
2026-08-17
Roscovitine, also called Seliciclib or CYC202, provides a practical way to connect CDK inhibition with cell-cycle phenotyping, dose-response analysis, and translational tumor studies. This guide combines executable assay parameters with cheminformatics principles for placing the compound in focused small-molecule collections and interpreting selectivity responsibly.